CVS Health Co. (NYSE:CVS - Free Report) - Equities researchers at Cantor Fitzgerald lifted their FY2025 earnings estimates for CVS Health in a note issued to investors on Thursday, February 13th. Cantor Fitzgerald analyst S. James now anticipates that the pharmacy operator will earn $5.86 per share for the year, up from their previous estimate of $5.71. Cantor Fitzgerald currently has a "Overweight" rating on the stock. The consensus estimate for CVS Health's current full-year earnings is $5.14 per share.
A number of other research analysts have also recently commented on the stock. Piper Sandler cut their price target on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a report on Monday, November 25th. Leerink Partners upgraded shares of CVS Health from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $55.00 to $75.00 in a report on Thursday. Leerink Partnrs upgraded shares of CVS Health from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 12th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price on the stock in a report on Tuesday, December 3rd. Finally, Royal Bank of Canada dropped their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and a consensus price target of $70.28.
View Our Latest Research Report on CVS
CVS Health Trading Down 1.0 %
Shares of NYSE CVS traded down $0.67 during mid-day trading on Friday, reaching $65.71. The company had a trading volume of 10,208,186 shares, compared to its average volume of 12,149,901. The business's 50-day moving average is $51.11 and its 200-day moving average is $55.99. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The stock has a market cap of $82.84 billion, a price-to-earnings ratio of 16.68, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. CVS Health has a 52 week low of $43.56 and a 52 week high of $80.75.
CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%.
Institutional Investors Weigh In On CVS Health
Hedge funds and other institutional investors have recently made changes to their positions in the company. Assetmark Inc. grew its stake in shares of CVS Health by 9.7% during the 3rd quarter. Assetmark Inc. now owns 410,001 shares of the pharmacy operator's stock worth $25,781,000 after purchasing an additional 36,132 shares during the period. TD Private Client Wealth LLC boosted its stake in CVS Health by 28.7% during the 3rd quarter. TD Private Client Wealth LLC now owns 46,938 shares of the pharmacy operator's stock worth $2,951,000 after purchasing an additional 10,465 shares during the last quarter. Cullinan Associates Inc. boosted its stake in CVS Health by 43.8% during the 3rd quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator's stock worth $7,125,000 after purchasing an additional 37,395 shares during the last quarter. Principal Financial Group Inc. boosted its stake in CVS Health by 4.8% during the 3rd quarter. Principal Financial Group Inc. now owns 1,434,476 shares of the pharmacy operator's stock worth $90,200,000 after purchasing an additional 66,244 shares during the last quarter. Finally, Sompo Asset Management Co. Ltd. boosted its stake in CVS Health by 8.4% during the 3rd quarter. Sompo Asset Management Co. Ltd. now owns 134,523 shares of the pharmacy operator's stock worth $8,459,000 after purchasing an additional 10,453 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.
CVS Health Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.05%. CVS Health's payout ratio is 72.68%.
CVS Health Company Profile
(
Get Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
